Within CLL, we developed a functional disease classification based on BCR, MEK, and mTOR signaling and demonstrate that the resulting groups are characterized by distinctive sensitivities to many drugs. Here, MAP2K7 is linked to B-cell chronic lymphocytic leukemia.